Max Robotics — Global Service Robot Directory + US Certification

About

Andrew Arther is a leading urologic surgeon and researcher whose work has fundamentally advanced the surgical treatment of benign prostatic hyperplasia (BPH), particularly for patients with large prostates. His primary research focus is the clinical application and long-term validation of Aquablation therapy, a minimally invasive, robotically guided water-jet ablation technique. Arther’s major contributions include landmark trials demonstrating that Aquablation provides durable symptom relief and a significantly lower rate of irreversible sexual side effects—specifically anejaculation—compared to traditional transurethral resection of the prostate (TURP). His most cited work, a 2019 study on men with prostates 80–150 cc, has garnered 63 citations and established Aquablation as a safe, effective option for this challenging patient population. A subsequent two-year follow-up (24 citations) confirmed sustained outcomes, while his subgroup analysis (42 citations) showed that men with large middle lobes or moderate symptoms derive particular benefit. Arther’s research has reshaped clinical guidelines and offers patients a compelling alternative to more invasive surgery, cementing his reputation as a pioneer in functional urology and robotic surgery.